BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22153350)

  • 1. Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging.
    Ma Y; Chiao YA; Zhang J; Manicone AM; Jin YF; Lindsey ML
    Microsc Microanal; 2012 Feb; 18(1):81-90. PubMed ID: 22153350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.
    Ma Y; Halade GV; Zhang J; Ramirez TA; Levin D; Voorhees A; Jin YF; Han HC; Manicone AM; Lindsey ML
    Circ Res; 2013 Feb; 112(4):675-88. PubMed ID: 23261783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction.
    Yabluchanskiy A; Ma Y; Chiao YA; Lopez EF; Voorhees AP; Toba H; Hall ME; Han HC; Lindsey ML; Jin YF
    Am J Physiol Heart Circ Physiol; 2014 May; 306(10):H1398-407. PubMed ID: 24658018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis.
    Toba H; Cannon PL; Yabluchanskiy A; Iyer RP; D'Armiento J; Lindsey ML
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H375-H383. PubMed ID: 28011588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging.
    Chiao YA; Dai Q; Zhang J; Lin J; Lopez EF; Ahuja SS; Chou YM; Lindsey ML; Jin YF
    Circ Cardiovasc Genet; 2011 Aug; 4(4):455-62. PubMed ID: 21685172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice.
    Chiao YA; Ramirez TA; Zamilpa R; Okoronkwo SM; Dai Q; Zhang J; Jin YF; Lindsey ML
    Cardiovasc Res; 2012 Dec; 96(3):444-55. PubMed ID: 22918978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice.
    Zavadzkas JA; Plyler RA; Bouges S; Koval CN; Rivers WT; Beck CU; Chang EI; Stroud RE; Mukherjee R; Spinale FG
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1394-402. PubMed ID: 18689500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization.
    Toba H; de Castro Brás LE; Baicu CF; Zile MR; Lindsey ML; Bradshaw AD
    Am J Physiol Cell Physiol; 2015 Jun; 308(12):C972-82. PubMed ID: 25877699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of extracellular matrix metalloproteinase inducer/CD147 induces altered cardiac extracellular matrix remodeling in aging mice.
    Huet E; Gabison E; Vallee B; Mougenot N; Linguet G; Riou B; Jarosz C; Menashi S; Besse S
    J Physiol Pharmacol; 2015 Jun; 66(3):355-66. PubMed ID: 26084217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
    Jenke A; Schur R; Röger C; Karadeniz Z; Grüger M; Holzhauser L; Savvatis K; Poller W; Schultheiss HP; Landmesser U; Skurk C
    Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Ikeuchi M; Shiomi T; Matsusaka H; Kubota T; Imanaka-Yoshida K; Itoh T; Takeshita A
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1229-35. PubMed ID: 12775562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Porphyromonas gingivalis lipopolysaccharide resets cardiac homeostasis in mice through a matrix metalloproteinase-9-dependent mechanism.
    Deleon-Pennell KY; de Castro Brás LE; Lindsey ML
    Physiol Rep; 2013 Oct; 1(5):e00079. PubMed ID: 24159380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-9-dependent mechanisms of reduced contractility and increased stiffness in the aging heart.
    Padmanabhan Iyer R; Chiao YA; Flynn ER; Hakala K; Cates CA; Weintraub ST; de Castro Brás LE
    Proteomics Clin Appl; 2016 Jan; 10(1):92-107. PubMed ID: 26415707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction.
    Zamilpa R; Lopez EF; Chiao YA; Dai Q; Escobar GP; Hakala K; Weintraub ST; Lindsey ML
    Proteomics; 2010 Jun; 10(11):2214-23. PubMed ID: 20354994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis.
    Johnson TL; Tulis DA; Keeler BE; Virag JA; Lust RM; Clemens S
    PLoS One; 2013; 8(8):e74116. PubMed ID: 24023697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
    Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac remodeling in erythropoietin-transgenic mice.
    Briest W; Homagk L; Baba HA; Deten A; Rassler B; Tannapfel A; Wagner KF; Wenger RH; Zimmer HG
    Cell Physiol Biochem; 2004; 14(4-6):277-84. PubMed ID: 15319531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.
    Matsumura S; Iwanaga S; Mochizuki S; Okamoto H; Ogawa S; Okada Y
    J Clin Invest; 2005 Mar; 115(3):599-609. PubMed ID: 15711638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction.
    Sun M; Dawood F; Wen WH; Chen M; Dixon I; Kirshenbaum LA; Liu PP
    Circulation; 2004 Nov; 110(20):3221-8. PubMed ID: 15533863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.